
FIGS (FIGS) Stock Forecast & Price Target
FIGS (FIGS) Analyst Ratings
Bulls say
FIGS is supported by durable demand for premium healthcare apparel, with core scrubs still driving the majority of revenue while active customers rose to 3.2 million and average order value increased to $126, signaling stronger monetization across cohorts. Its growth case is broadened by international momentum, non-scrubwear expansion, TEAMS, and Community Hubs, with revenue up 25.7% to $190.7 million and international sales surging 51%, suggesting multiple incremental levers beyond the U.S. core. Fundamentally, profitability is also improving as opex fell to 57.6% from 63.6% and adjusted EBITDA margin reached 16.5%, while a cash-rich, debt-free balance sheet and raised guidance reinforce confidence that growth can compound with operating leverage.
Bears say
FIGS is vulnerable to a sharper-than-expected slowdown as roughly 80% of sales come from the U.S., making growth dependent on a core market that may lose momentum after prior-period strength. Margin upside also looks fragile because gross margin could normalize as tariff refunds fade, while selling expenses of about 22% of sales and G&A ex-SBC of about 21% suggest customer acquisition and operating leverage may remain weak. Its expansion into international, TEAMS/B2B at about 7% of sales, and non-scrub categories has yet to prove it can offset core scrubwear commoditization, and China-based sourcing adds regulatory, political, and cost risk.
This aggregate rating is based on analysts' research of FIGS and is not a guaranteed prediction by Public.com or investment advice.
FIGS (FIGS) Analyst Forecast & Price Prediction
Start investing in FIGS (FIGS)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About FIGS (FIGS) Forecast
FIGS (FIGS) Analyst Forecast & Price Prediction
Start investing in FIGS (FIGS)
Order type
Buy in
Order amount
Est. shares
0 shares